Megha Katare Pandey
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Megha Katare Pandey has a total of 85 co-authors. Here are the top co-authors by number of shared publications:
- Rekha Khandia
Department of Biochemistry and Genetics, Barkatullah University, Bhopal, India
5 shared publications - Azmat Ali Khan
Pharmaceutical Biotechnology Laboratory, Department of Pharmaceutical Chemistry, College of Pharmacy King Saud University Riyadh Saudi Arabia
3 shared publications - Pankaj Gurjar
Centre for Global Health Research, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu, India
3 shared publications Poonam Parihar
Dept of Translational Medicine, All India Institute of Medical Sciences, Bhopal, 462020, India
3 shared publicationsRohan Shrivastava
Dept of Translational Medicine, All India Institute of Medical Sciences, Bhopal, 462020, India
3 shared publicationsSomesh Mishra
Dept of Translational Medicine, All India Institute of Medical Sciences, Bhopal, 462020, India
3 shared publications
Latest Publications
- 3 July 2026
- Published by Springer Nature in Molecular Biology Reports
- Vol. 53 (1)
Development and clinical validation of a PCR assay for human parvovirus B19 detection with applications in challenging diagnostic scenarios
Human parvovirus B19 (HB19V) infection poses significant clinical challenges in resource-limited settings, particularly regarding blood safety surveillance and diagnosis of associated syndromes. Limited access to validated diagnostic assays restricts clinical management and transfusion safety protocols. The objective is to develop and validate an in-house duplex real-time PCR assay for HB19V detection and evaluate its clinical utility in a resource-limited setting. A duplex real-time PCR assay targeting the conserved NS1 gene of HB19V with RNase P as endogenous control was developed. Analytical validation assessed amplification efficiency, limit of detection (LOD), precision (intra- and inter-assay coefficients of variation), and cross-reactivity. Clinical validation compared qualitative agreement with a CE-certified commercial kit using Cohen's kappa statistic. Positive samples underwent Sanger sequencing for genotype characterization. Clinical specimens from suspected HB19V infections were tested and results correlated with patient presentations. The assay demonstrated 98.82% amplification efficiency with LOD of 6 copies/µL. Precision metrics showed excellent reproducibility (CoV < 1% intra-assay, < 5% inter-assay) with no cross-reactivity. Qualitative agreement with the commercial reference was 100% (Cohen's kappa > 0.95). Clinical application identified three significant cases: post-transfusion HB19V in neonatal bilirubin encephalopathy, HB19V consideration in severe anaemia with ventriculitis, and active infection in paediatric Ewing sarcoma with chemotherapy-induced cytopenias requiring IVIG therapy. Genotyping revealed genotypes 1a and 3, confirming regional viral diversity. This validated in-house duplex real-time PCR assay provides a cost-effective, locally sustainable diagnostic tool for HB19V detection. It addresses critical gaps in blood safety surveillance and expands diagnostic capacity for HB19V-associated syndromes in resource-limited settings, while highlighting the necessity of contextual clinical interpretation for optimal patient management.
- 3 July 2026
- Published by Springer Nature in Molecular Biology Reports
- Vol. 53 (1)
Development and clinical validation of a PCR assay for human parvovirus B19 detection with applications in challenging diagnostic scenarios
Human parvovirus B19 (HB19V) infection poses significant clinical challenges in resource-limited settings, particularly regarding blood safety surveillance and diagnosis of associated syndromes. Limited access to validated diagnostic assays restricts clinical management and transfusion safety protocols. The objective is to develop and validate an in-house duplex real-time PCR assay for HB19V detection and evaluate its clinical utility in a resource-limited setting. A duplex real-time PCR assay targeting the conserved NS1 gene of HB19V with RNase P as endogenous control was developed. Analytical validation assessed amplification efficiency, limit of detection (LOD), precision (intra- and inter-assay coefficients of variation), and cross-reactivity. Clinical validation compared qualitative agreement with a CE-certified commercial kit using Cohen's kappa statistic. Positive samples underwent Sanger sequencing for genotype characterization. Clinical specimens from suspected HB19V infections were tested and results correlated with patient presentations. The assay demonstrated 98.82% amplification efficiency with LOD of 6 copies/µL. Precision metrics showed excellent reproducibility (CoV < 1% intra-assay, < 5% inter-assay) with no cross-reactivity. Qualitative agreement with the commercial reference was 100% (Cohen's kappa > 0.95). Clinical application identified three significant cases: post-transfusion HB19V in neonatal bilirubin encephalopathy, HB19V consideration in severe anaemia with ventriculitis, and active infection in paediatric Ewing sarcoma with chemotherapy-induced cytopenias requiring IVIG therapy. Genotyping revealed genotypes 1a and 3, confirming regional viral diversity. This validated in-house duplex real-time PCR assay provides a cost-effective, locally sustainable diagnostic tool for HB19V detection. It addresses critical gaps in blood safety surveillance and expands diagnostic capacity for HB19V-associated syndromes in resource-limited settings, while highlighting the necessity of contextual clinical interpretation for optimal patient management.
- Open Access
- 2 June 2026
- Published by Springer Nature in Cureus
- Vol. 18 (6) , e110087
Human Exposure to Micro- and Nanoplastics and Their Potential Neurological Implications: A Systematic Review of Emerging Evidence
The growing prevalence of micro- and nanoplastics (MNPs) in the environment elicits concerns about their possible impact on human neurological health. Although studies on animals have suggested neurotoxic effects, evidence from humans is still scarce. This systematic review gathers existing human data to assess the presence, types, detection techniques, and neurological consequences of MNPs in different biological matrices. A comprehensive review was performed on peer-reviewed research concentrating on human studies that report the detection of MNPs in biological tissues and fluids. Four qualifying studies were identified: one clinical observational study, two cadaveric analyses, and one quasi-experimental trial. The data collected encompassed demographics, detection methods, types and concentrations of polymers, biological matrices examined, and neurological biomarkers. MNPs were observed in cerebrospinal fluid (CSF), faeces, urine, olfactory bulbs (OBs), and in brain, liver, and kidney tissues from postmortem cases. The polymers that were reported most frequently were polyethylene (PE) and polypropylene (PP). The detection methods included micro-Fourier transform infrared spectroscopy (µFTIR), pyrolysis-gas chromatography/mass spectrometry (Py-GC/MS), laser direct infrared imaging (LDIR), scanning electron microscopy (SEM), and transmission electron microscopy (TEM). Although the available evidence is limited, emerging findings indicate the possible accumulation of MNPs in the human central nervous system (CNS), particularly in individuals with dementia or compromised blood-brain barrier (BBB) integrity. Relationships were noted between MNP exposure and disruptions in the BBB, inflammatory markers, and alterations in the gut-brain axis. This review consolidates the findings and emphasizes the need for further exploration of human exposure to MNPs and their possible accumulation in neural tissues. Although there is variability in methodologies used in the reviewed articles, PE and PP stand out as the primary polymers of concern. While a direct causal relationship cannot yet be confirmed, the results highlight the necessity for improved detection methods, larger sample sizes, and long-term studies to better understand the impact of MNPs on neuroinflammation and neurodegeneration.
- 2 June 2026
- Published by Springer Nature in Cureus
- Vol. 18 (6) , e110087
Open AccessHuman Exposure to Micro- and Nanoplastics and Their Potential Neurological Implications: A Systematic Review of Emerging Evidence
The growing prevalence of micro- and nanoplastics (MNPs) in the environment elicits concerns about their possible impact on human neurological health. Although studies on animals have suggested neurotoxic effects, evidence from humans is still scarce. This systematic review gathers existing human data to assess the presence, types, detection techniques, and neurological consequences of MNPs in different biological matrices. A comprehensive review was performed on peer-reviewed research concentrating on human studies that report the detection of MNPs in biological tissues and fluids. Four qualifying studies were identified: one clinical observational study, two cadaveric analyses, and one quasi-experimental trial. The data collected encompassed demographics, detection methods, types and concentrations of polymers, biological matrices examined, and neurological biomarkers. MNPs were observed in cerebrospinal fluid (CSF), faeces, urine, olfactory bulbs (OBs), and in brain, liver, and kidney tissues from postmortem cases. The polymers that were reported most frequently were polyethylene (PE) and polypropylene (PP). The detection methods included micro-Fourier transform infrared spectroscopy (µFTIR), pyrolysis-gas chromatography/mass spectrometry (Py-GC/MS), laser direct infrared imaging (LDIR), scanning electron microscopy (SEM), and transmission electron microscopy (TEM). Although the available evidence is limited, emerging findings indicate the possible accumulation of MNPs in the human central nervous system (CNS), particularly in individuals with dementia or compromised blood-brain barrier (BBB) integrity. Relationships were noted between MNP exposure and disruptions in the BBB, inflammatory markers, and alterations in the gut-brain axis. This review consolidates the findings and emphasizes the need for further exploration of human exposure to MNPs and their possible accumulation in neural tissues. Although there is variability in methodologies used in the reviewed articles, PE and PP stand out as the primary polymers of concern. While a direct causal relationship cannot yet be confirmed, the results highlight the necessity for improved detection methods, larger sample sizes, and long-term studies to better understand the impact of MNPs on neuroinflammation and neurodegeneration.
- Open Access
- 30 March 2026
- Published by MDPI AG in Current Oncology
- Vol. 33 (4) , 194
Ferroptosis-Based Nanotherapeutic Strategies to Overcome Temozolomide Resistance in Glioblastoma: A Systematic Review and Meta-Analysis
Glioblastoma multiforme (GBM) is one of the most aggressive and treatment-resistant forms of brain cancer, posing challenges to modern oncology. Current treatments, including surgery, radiation, and chemotherapy (e.g., Temozolomide or TMZ), often fail due to the inevitable development of drug resistance. TMZ resistance remains a major therapeutic challenge for the reasons that it is the first-line treatment. Recent studies indicate a rising GBM tumour burden and a trend towards earlier age of onset. It highlights the urgent need for evidence-based policymaking and intensified research to address this most difficult-to-treat malignancy in clinical settings. Ferroptosis, a newly recognized type of controlled cell death induced by iron-dependent lipid peroxidation, has emerged as a potential approach to overcome apoptosis resistance and restore drug sensitivity in GBM. This mechanism is modulated by key molecules that can be specifically targeted to either enhance oxidative stress or inhibit antioxidant defences, ultimately leading to tumour cell death. This review conducts a meta-analysis of preclinical evidence to better understand the potential of activating ferroptosis as a key target for developing nanoparticles to resensitize TMZ-resistant GBM cells. Current evidence indicates that combining ferroptosis induction with strategically engineered nanocarrier systems can serve as a novel and effective therapeutic approach to overcome TMZ resistance and advance precision-based GBM treatment.
- 30 March 2026
- Published by MDPI AG in Current Oncology
- Vol. 33 (4) , 194
Open AccessFerroptosis-Based Nanotherapeutic Strategies to Overcome Temozolomide Resistance in Glioblastoma: A Systematic Review and Meta-Analysis
Glioblastoma multiforme (GBM) is one of the most aggressive and treatment-resistant forms of brain cancer, posing challenges to modern oncology. Current treatments, including surgery, radiation, and chemotherapy (e.g., Temozolomide or TMZ), often fail due to the inevitable development of drug resistance. TMZ resistance remains a major therapeutic challenge for the reasons that it is the first-line treatment. Recent studies indicate a rising GBM tumour burden and a trend towards earlier age of onset. It highlights the urgent need for evidence-based policymaking and intensified research to address this most difficult-to-treat malignancy in clinical settings. Ferroptosis, a newly recognized type of controlled cell death induced by iron-dependent lipid peroxidation, has emerged as a potential approach to overcome apoptosis resistance and restore drug sensitivity in GBM. This mechanism is modulated by key molecules that can be specifically targeted to either enhance oxidative stress or inhibit antioxidant defences, ultimately leading to tumour cell death. This review conducts a meta-analysis of preclinical evidence to better understand the potential of activating ferroptosis as a key target for developing nanoparticles to resensitize TMZ-resistant GBM cells. Current evidence indicates that combining ferroptosis induction with strategically engineered nanocarrier systems can serve as a novel and effective therapeutic approach to overcome TMZ resistance and advance precision-based GBM treatment.
- Open Access
- 5 February 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Development of in-house PCR assays and cross-sectional molecular surveillance of infectious pathogens in adverse pregnancy outcomes and neonatal sepsis in central India
Adverse pregnancy outcomes (APOs), including spontaneous abortion, stillbirth, and neonatal sepsis, are major contributors to maternal and neonatal morbidi
- 5 February 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Open AccessDevelopment of in-house PCR assays and cross-sectional molecular surveillance of infectious pathogens in adverse pregnancy outcomes and neonatal sepsis in central India
Adverse pregnancy outcomes (APOs), including spontaneous abortion, stillbirth, and neonatal sepsis, are major contributors to maternal and neonatal morbidi
- Open Access
- 12 December 2025
- Published by Elsevier in Journal of Global Antimicrobial Resistance
- Vol. 46, 148-157
Integrative machine learning approaches with genomic data for predicting antitubercular drug resistance: A systematic review and meta-analysis
- 12 December 2025
- Published by Elsevier in Journal of Global Antimicrobial Resistance
- Vol. 46, 148-157
Open AccessIntegrative machine learning approaches with genomic data for predicting antitubercular drug resistance: A systematic review and meta-analysis
- Open Access
Highly Pathogenic Avian Influenza A (H5N1) Clade 2.3.2.1a virus infection in domestic cats, India, 2025
In January 2025, the highly pathogenic avian influenza A(H5N1) virus clade 2.3.2.1a infection was detected in domestic cats and whole-genome sequencing of two cat H5N1 isolates was performed using the Oxford Nanopore MinION sequencing platform. Phylogenetic analysis revealed the circulation of triple reassortant viruses in cats. Although cat viruses lacked classic mammalian adaptation markers they carried mutations associated with enhanced polymerase activity in mammalian cells and increased affinity for α2–6 sialic acid receptor suggesting their potential role in facilitating infection in cats. The identification of reassortant HPAI H5N1 clade 2.3.2.1a viruses in domestic cats in India highlights the urgent need for enhanced surveillance in domestic poultry, wild birds, and mammals, including humans, to track genomic diversity and molecular evolution of circulating strains.
Open AccessHighly Pathogenic Avian Influenza A (H5N1) Clade 2.3.2.1a virus infection in domestic cats, India, 2025
In January 2025, the highly pathogenic avian influenza A(H5N1) virus clade 2.3.2.1a infection was detected in domestic cats and whole-genome sequencing of two cat H5N1 isolates was performed using the Oxford Nanopore MinION sequencing platform. Phylogenetic analysis revealed the circulation of triple reassortant viruses in cats. Although cat viruses lacked classic mammalian adaptation markers they carried mutations associated with enhanced polymerase activity in mammalian cells and increased affinity for α2–6 sialic acid receptor suggesting their potential role in facilitating infection in cats. The identification of reassortant HPAI H5N1 clade 2.3.2.1a viruses in domestic cats in India highlights the urgent need for enhanced surveillance in domestic poultry, wild birds, and mammals, including humans, to track genomic diversity and molecular evolution of circulating strains.
- Open Access
- 19 February 2025
- Published by Springer Nature in Virology Journal
- Vol. 22 (1) , 1-12
Exploring the link between parvovirus B19 and encephalitis: a systematic review and comprehensive meta-analysis of molecular and serological evidence
Encephalitis, a severe brain inflammation, can arise due to various infectious agents, including viruses like Parvovirus B19 (B19V). Previously linked to mild neonatal and young one’s illnesses and some haematological diseases, recent evidence associates B19V with encephalitis, with no clear prevalence and mechanisms in place. This systematic review and meta-analysis aim to determine the prevalence of B19V in cases of encephalitis, exploring variations associated with diagnostic approaches, and identifying gaps in existing research to enhance clinical comprehension and diagnostic methods. An extensive search (1994–2024) was performed through PubMed, Scopus, ScienceDirect, and Cochrane databases for research and epidemiological investigations related to B19V in cases of encephalitis. Inclusion criteria focused on studies that verified B19V using molecular (PCR, NGS) or serological (IgM/IgG) techniques in cerebrospinal fluid or serum. Data analysis was done to pool the prevalence data of included studies using a random-effects model. Heterogeneity was evaluated using I2 statistics. Sensitivity and meta-regression analyses were conducted to evaluate variability and the effects of moderators. A total of fourteen studies involving 3,135 encephalitis patients resulted in a combined prevalence of 3% (95% CI: 2–4%). Studies using PCR indicated a greater prevalence (3%) in comparison to ELISA (1%) and NGS (2%). A moderate level of heterogeneity (I2 = 57.4%) was attributed to the variability in diagnostic methods and geographic distribution. Sensitivity analyses validated strong estimates, while meta-regression revealed country as a key moderator accounting for heterogeneity. Publication bias was modest. The research indicates that B19V may be involved in certain encephalitis instances, with an overall prevalence of 3%. The differences observed in the studies emphasize the need for standardized diagnostic procedures and more extensive multicentric epidemiological research.
- 19 February 2025
- Published by Springer Nature in Virology Journal
- Vol. 22 (1) , 1-12
Open AccessExploring the link between parvovirus B19 and encephalitis: a systematic review and comprehensive meta-analysis of molecular and serological evidence
Encephalitis, a severe brain inflammation, can arise due to various infectious agents, including viruses like Parvovirus B19 (B19V). Previously linked to mild neonatal and young one’s illnesses and some haematological diseases, recent evidence associates B19V with encephalitis, with no clear prevalence and mechanisms in place. This systematic review and meta-analysis aim to determine the prevalence of B19V in cases of encephalitis, exploring variations associated with diagnostic approaches, and identifying gaps in existing research to enhance clinical comprehension and diagnostic methods. An extensive search (1994–2024) was performed through PubMed, Scopus, ScienceDirect, and Cochrane databases for research and epidemiological investigations related to B19V in cases of encephalitis. Inclusion criteria focused on studies that verified B19V using molecular (PCR, NGS) or serological (IgM/IgG) techniques in cerebrospinal fluid or serum. Data analysis was done to pool the prevalence data of included studies using a random-effects model. Heterogeneity was evaluated using I2 statistics. Sensitivity and meta-regression analyses were conducted to evaluate variability and the effects of moderators. A total of fourteen studies involving 3,135 encephalitis patients resulted in a combined prevalence of 3% (95% CI: 2–4%). Studies using PCR indicated a greater prevalence (3%) in comparison to ELISA (1%) and NGS (2%). A moderate level of heterogeneity (I2 = 57.4%) was attributed to the variability in diagnostic methods and geographic distribution. Sensitivity analyses validated strong estimates, while meta-regression revealed country as a key moderator accounting for heterogeneity. Publication bias was modest. The research indicates that B19V may be involved in certain encephalitis instances, with an overall prevalence of 3%. The differences observed in the studies emphasize the need for standardized diagnostic procedures and more extensive multicentric epidemiological research.
- 6 August 2024
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 278 (Pt 1) , 134480
Determination of codon pattern and evolutionary forces acting on genes linked to inflammatory bowel disease
- 6 August 2024
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 278 (Pt 1) , 134480
Determination of codon pattern and evolutionary forces acting on genes linked to inflammatory bowel disease
- 14 November 2023
- Published by Taylor & Francis
- p. 338-349
Biotechnological, Agriculture, Industrial, and Biopharmaceutical Research in Bioinformatics
Bioinformatics is an interdisciplinary field, comprising various approaches and tools of computation and analysis to store, manage, and interpret biological data. Advancements in bioinformatics and the integration of multiple omics technologies have made the analysis and interpretation of biological complexity possible at a rapid pace, particularly in areas involving sequence data processing and drug design. Biotechnology is interconnected with bioinformatics in many ways like nucleotide sequence analysis, phylogenetic analysis, protein and DNA modeling, protein-protein and/or protein-ligand docking, metagenomics, and metabolomics including microbial, plant, animal, and human and studies. Bioinformatics allows for a wide range of technologies to be used for retrieving coding sequences of protein and mRNA from datasets repositories, 3D-structural modeling, and interpretation. CRISPR-Cas9-based genetic engineering for agricultural bacteria and many other agriculture bioinformatics that are used for crop improvement are all examples of bioinformatics’ potential. In order to gain a better understanding of biopharmaceutical activity and function, bioinformatics tools might help in the study of the evolutionary relationship of genes in the entire genome sequences of various microalgal species. The ability to investigate the phylogenetic and effective constituents of microbial populations that have prominent significance in industrial processes has massively increased due to advancements in bioinformatics. As a result, bioinformatics applications have increased in the corporate sector, where altered microbiomes play a vital role in producing food, probiotics, nutraceuticals, cosmetics, and enzymes exploration. Moreover, one of the bioinformatics applications includes codon usage bias (CUB) analysis. It is extensively used in cell biology, genetics, and functional expression of genes. CUB is one of the approaches used in novel drug discovery. Attenuation of viruses to prevent any health hazards while boosting a strong immune response is one of the novel approaches based on codon usage bias manipulation. Furthermore, several protein targets are created by heterologous expression of transgenic proteins, which involves rearranging the coding sequence(s) from the innate sequence(s) to optimize the protein translation in specific host machinery. Several studies based on the elucidation of codon usage patterns of emerging pathogens helped in establishing approaches to modify their genomes to mitigate virulence and reveal the pathogen’s replicative efficiency in human hosts for creating a clinically efficient vaccine.
- 14 November 2023
- Published by Taylor & Francis
- p. 338-349
Biotechnological, Agriculture, Industrial, and Biopharmaceutical Research in Bioinformatics
Bioinformatics is an interdisciplinary field, comprising various approaches and tools of computation and analysis to store, manage, and interpret biological data. Advancements in bioinformatics and the integration of multiple omics technologies have made the analysis and interpretation of biological complexity possible at a rapid pace, particularly in areas involving sequence data processing and drug design. Biotechnology is interconnected with bioinformatics in many ways like nucleotide sequence analysis, phylogenetic analysis, protein and DNA modeling, protein-protein and/or protein-ligand docking, metagenomics, and metabolomics including microbial, plant, animal, and human and studies. Bioinformatics allows for a wide range of technologies to be used for retrieving coding sequences of protein and mRNA from datasets repositories, 3D-structural modeling, and interpretation. CRISPR-Cas9-based genetic engineering for agricultural bacteria and many other agriculture bioinformatics that are used for crop improvement are all examples of bioinformatics’ potential. In order to gain a better understanding of biopharmaceutical activity and function, bioinformatics tools might help in the study of the evolutionary relationship of genes in the entire genome sequences of various microalgal species. The ability to investigate the phylogenetic and effective constituents of microbial populations that have prominent significance in industrial processes has massively increased due to advancements in bioinformatics. As a result, bioinformatics applications have increased in the corporate sector, where altered microbiomes play a vital role in producing food, probiotics, nutraceuticals, cosmetics, and enzymes exploration. Moreover, one of the bioinformatics applications includes codon usage bias (CUB) analysis. It is extensively used in cell biology, genetics, and functional expression of genes. CUB is one of the approaches used in novel drug discovery. Attenuation of viruses to prevent any health hazards while boosting a strong immune response is one of the novel approaches based on codon usage bias manipulation. Furthermore, several protein targets are created by heterologous expression of transgenic proteins, which involves rearranging the coding sequence(s) from the innate sequence(s) to optimize the protein translation in specific host machinery. Several studies based on the elucidation of codon usage patterns of emerging pathogens helped in establishing approaches to modify their genomes to mitigate virulence and reveal the pathogen’s replicative efficiency in human hosts for creating a clinically efficient vaccine.
- Open Access
- 13 June 2023
- Published by Frontiers Media SA in Frontiers in Molecular Neuroscience
- Vol. 16, 1200523
Application of codon usage and context analysis in genes up- or down-regulated in neurodegeneration and cancer to combat comorbidities
Introduction: Neurodegeneration and cancer present in comorbidities with inverse effects due to the expression of genes and pathways acting in opposition. Identifying and studying the genes simultaneously up or downregulated during morbidities helps curb both ailments together.Methods: This study examines four genes. Three of these (Amyloid Beta Precursor Protein (APP), Cyclin D1 (CCND1), and Cyclin E2 (CCNE2) are upregulated, and one protein phosphatase 2 phosphatase activator (PTPA) is simultaneously downregulated in both disorders. We investigated molecular patterns, codon usage, codon usage bias, nucleotide bias in the third codon position, preferred codons, preferred codon pairs, rare codons, and codon context.Results: Parity analysis revealed that T is preferred over A, and G is preferred over C in the third codon position, suggesting composition plays no role in nucleotide bias in both the upregulated and downregulated gene sets and that mutational forces are stronger in upregulated gene sets than in downregulated ones. Transcript length influenced the overall %A composition and codon bias, and the codon AGG exerted the strongest influence on codon usage in both the upregulated and downregulated gene sets. Codons ending in G/C were preferred for 16 amino acids, and glutamic acid-, aspartic acid-, leucine-, valine-, and phenylalanine-initiated codon pairs were preferred in all genes. Codons CTA (Leu), GTA (Val), CAA (Gln), and CGT (Arg) were underrepresented in all examined genes.Discussion: Using advanced gene editing tools such as CRISPR/Cas or any other gene augmentation technique, these recoded genes may be introduced into the human body to optimize gene expression levels to augment neurodegeneration and cancer therapeutic regimens simultaneously.
- 13 June 2023
- Published by Frontiers Media SA in Frontiers in Molecular Neuroscience
- Vol. 16, 1200523
Open AccessApplication of codon usage and context analysis in genes up- or down-regulated in neurodegeneration and cancer to combat comorbidities
Introduction: Neurodegeneration and cancer present in comorbidities with inverse effects due to the expression of genes and pathways acting in opposition. Identifying and studying the genes simultaneously up or downregulated during morbidities helps curb both ailments together.Methods: This study examines four genes. Three of these (Amyloid Beta Precursor Protein (APP), Cyclin D1 (CCND1), and Cyclin E2 (CCNE2) are upregulated, and one protein phosphatase 2 phosphatase activator (PTPA) is simultaneously downregulated in both disorders. We investigated molecular patterns, codon usage, codon usage bias, nucleotide bias in the third codon position, preferred codons, preferred codon pairs, rare codons, and codon context.Results: Parity analysis revealed that T is preferred over A, and G is preferred over C in the third codon position, suggesting composition plays no role in nucleotide bias in both the upregulated and downregulated gene sets and that mutational forces are stronger in upregulated gene sets than in downregulated ones. Transcript length influenced the overall %A composition and codon bias, and the codon AGG exerted the strongest influence on codon usage in both the upregulated and downregulated gene sets. Codons ending in G/C were preferred for 16 amino acids, and glutamic acid-, aspartic acid-, leucine-, valine-, and phenylalanine-initiated codon pairs were preferred in all genes. Codons CTA (Leu), GTA (Val), CAA (Gln), and CGT (Arg) were underrepresented in all examined genes.Discussion: Using advanced gene editing tools such as CRISPR/Cas or any other gene augmentation technique, these recoded genes may be introduced into the human body to optimize gene expression levels to augment neurodegeneration and cancer therapeutic regimens simultaneously.